Search

everythinglearnresearchcommunity

for

Search:↓

Educators who survived COVID-19 faced physical, psychological, and social challenges but overcame them with resilience and support, highlighting the need for schools to provide better health and psychological care.

Cancer patients with COVID-19 face higher risks due to possible additional infections.

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Social media data can help track and predict COVID-19 symptoms and trends.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

Natural plant compounds may offer safer COVID-19 treatments with fewer side effects.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Hematopoietic stem cell transplantation does not significantly affect COVID-19 severity in children with immune disorders.

Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Booster doses of Covaxin improve protection against the Omicron variant.

Long-COVID symptoms like fatigue, cognitive issues, and mobility problems can last 6-12 months but are less common after milder illness.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

Anti-angiogenic drugs do not worsen COVID-19 severity in lung cancer patients.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Severe hair loss is linked to worse COVID-19 outcomes, especially in younger men.

Women with PCOS are more vulnerable to severe COVID-19 and related health issues.

Low testosterone may indicate severe COVID-19 in men.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

People with androgenetic alopecia may have a higher risk of severe COVID-19.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Targeting endolysosomes may help treat COVID-19.

An 84-year-old man developed severe anemia after his first COVID-19 vaccine shot, improved with treatment, and was advised against a second dose.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

Some patients on Baricitinib for alopecia areata lost response, often linked to longer and more severe initial conditions.